Anglo-French Drugs & Industries reports standalone net loss of Rs 3.35 crore in the December 2023 quarter

Anglo-French Drugs & Industries reports standalone Robust growth: Sales Soar by 36.78% and Net Loss declines significantly for the quarter ended Dec 23

Expert Analysis:

• Sales Surge:

  • Impressive 36.78% Growth to Rs 25.66 crore.

• Financial Turnaround:

  • Net Loss Narrows from Rs 7.06 crore from the previous quarter ended Dec 22 to Rs 3.35 crore for the quarter ended Dec 23.

• Operational Efficiency:

  • OPM Improves from -38.43% to -10.05%.